BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2035 related articles for article (PubMed ID: 15585605)

  • 1. Toll-like receptors in innate immunity.
    Takeda K; Akira S
    Int Immunol; 2005 Jan; 17(1):1-14. PubMed ID: 15585605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution and integration of innate immune recognition systems: the Toll-like receptors.
    Takeda K
    J Endotoxin Res; 2005; 11(1):51-5. PubMed ID: 15826379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of innate immune responses by Toll-like receptors.
    Takeda K; Akira S
    Jpn J Infect Dis; 2001 Dec; 54(6):209-19. PubMed ID: 11862002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [TIR domain--containing adaptors regulate TLR-mediated signaling pathways].
    Yamamoto M; Akira S
    Nihon Rinsho; 2004 Dec; 62(12):2197-203. PubMed ID: 15597785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense.
    Dunne A; O'Neill LA
    Sci STKE; 2003 Feb; 2003(171):re3. PubMed ID: 12606705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system.
    Netea MG; van der Graaf C; Van der Meer JW; Kullberg BJ
    J Leukoc Biol; 2004 May; 75(5):749-55. PubMed ID: 15075354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogen recognition with Toll-like receptors.
    Kawai T; Akira S
    Curr Opin Immunol; 2005 Aug; 17(4):338-44. PubMed ID: 15950447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor signaling pathways.
    Barton GM; Medzhitov R
    Science; 2003 Jun; 300(5625):1524-5. PubMed ID: 12791976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial modulation of mucosal innate immunity.
    Kelly D; Conway S
    Mol Immunol; 2005 May; 42(8):895-901. PubMed ID: 15829279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primers on molecular pathways: lipopolysaccharide signaling - potential role in pancreatitis and pancreatic cancer.
    Del Pozo JL
    Pancreatology; 2010; 10(2-3):114-8. PubMed ID: 20460943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal integration following Toll-like receptor triggering.
    Dalpke A; Heeg K
    Crit Rev Immunol; 2002; 22(3):217-50. PubMed ID: 12498384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signalling of toll-like receptors.
    Brikos C; O'Neill LA
    Handb Exp Pharmacol; 2008; (183):21-50. PubMed ID: 18071653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptors.
    Lien E; Ingalls RR
    Crit Care Med; 2002 Jan; 30(1 Suppl):S1-11. PubMed ID: 11782555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiinfective host defense mechanism: toll-like receptors and innate immunity].
    Takesue Y; Ohge H; Kohyama M; Imamura Y; Murakami Y; Sueda T
    Nihon Geka Gakkai Zasshi; 2003 Jul; 104(7):494-8. PubMed ID: 12884772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR signaling.
    Kawai T; Akira S
    Semin Immunol; 2007 Feb; 19(1):24-32. PubMed ID: 17275323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic zebrafish reporter lines reveal conserved Toll-like receptor signaling potential in embryonic myeloid leukocytes and adult immune cell lineages.
    Hall C; Flores MV; Chien A; Davidson A; Crosier K; Crosier P
    J Leukoc Biol; 2009 May; 85(5):751-65. PubMed ID: 19218482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How we detect microbes and respond to them: the Toll-like receptors and their transducers.
    Beutler B; Hoebe K; Du X; Ulevitch RJ
    J Leukoc Biol; 2003 Oct; 74(4):479-85. PubMed ID: 12960260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Receptors and signal proteins of the innate immune system as new targets in sepsis therapy. Reprogramming of the immune response].
    Holzmann B; Weighardt H; Heidecke CD
    Chirurg; 2003 Jan; 74(1):61-4. PubMed ID: 12552407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor control of the adaptive immune responses.
    Iwasaki A; Medzhitov R
    Nat Immunol; 2004 Oct; 5(10):987-95. PubMed ID: 15454922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 102.